GSK Executive Discusses Vaccine R&D Investments, Challenges

Bloomberg TV: Upfront Vaccine Costs a Hurdle to Business: Slaoui
In a video report, “Moncef Slaoui, R&D and vaccines chairman at GlaxoSmithKline, discusses the financial challenges to developing vaccines, the importance of research and development to the pharmaceutical industry from the 2014 Milken Global Conference on Bloomberg Television’s ‘Market Makers'” (4/29).